Matthijs Oyaert
Overview
Explore the profile of Matthijs Oyaert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
455
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lambrecht S, Speeckaert M, Oyaert M
BMC Nephrol
. 2025 Mar;
26(1):130.
PMID: 40065231
Introduction: Clinical laboratories play an important role in the diagnosis and monitoring of chronic kidney disease (CKD). Our aim was to evaluate the performance of qualitative and semi-quantitative albumin-to-creatinine ratio...
2.
Oyaert M, Kouri T, Carton E, Deprez S, Lambrecht S, Speeckaert M
Clin Chem Lab Med
. 2025 Jan;
PMID: 39873439
Objectives: We evaluated the performance of a novel flow cell morphology analyzer AUTION EYE AI-4510 for counting particles in urine. Methods: Analytical performance was assessed according to the EFLM European...
3.
Van Hoovels L, Vanhove B, Decavele A, Capron A, Oyaert M
Acta Clin Belg
. 2024 Oct;
:1-9.
PMID: 39392078
Objectives/background: We aimed to investigate routine urinalysis practices in Belgian laboratories and verify these findings against the 2023 European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) European Urinalysis Guideline....
4.
Oyaert M, Verougstraete N, Vandekerckhove B, Lapauw B, Hoste E, Stove V
Clin Biochem
. 2024 Sep;
133-134:110829.
PMID: 39349157
Introduction: Discrepancies between electrolyte concentrations determined by blood gas analysers (BGA) and core-lab chemistry analysers may create confusion in clinical practice. This problem is rooted in the different ion-selective electrode...
5.
Delrue C, De Bruyne S, Oyaert M, Delanghe J, Moresco R, Speeckaert R, et al.
Int J Mol Sci
. 2024 Jun;
25(11).
PMID: 38892184
The early detection of gynecological cancers, which is critical for improving patient survival rates, is challenging because of the vague early symptoms and the diagnostic limitations of current approaches. This...
6.
Miske R, Scharf M, Borowski K, Specht I, Corty M, Loritz M, et al.
J Neurol Neurosurg Psychiatry
. 2024 Apr;
95(11):1064-1076.
PMID: 38663995
Background: We aimed to investigate the clinical, imaging and fluid biomarker characteristics in patients with antidiacylglycerol lipase alpha (DAGLA)-autoantibody-associated cerebellitis. Methods: Serum and cerebrospinal fliud (CSF) samples from four index...
7.
Kouri T, Hofmann W, Falbo R, Oyaert M, Schubert S, Gertsen J, et al.
Clin Chem Lab Med
. 2024 Mar;
62(9):1653-1786.
PMID: 38534005
Background: The EFLM Task and Finish Group Urinalysis has updated the ECLM European Urinalysis Guidelines (2000) on urinalysis and urine bacterial culture, to improve accuracy of these examinations in European...
8.
Delrue C, Speeckaert R, Oyaert M, Kerre T, Rottey S, Coopman R, et al.
Int J Mol Sci
. 2023 Dec;
24(23).
PMID: 38069330
Hematological diseases, due to their complex nature and diverse manifestations, pose significant diagnostic challenges in healthcare. The pressing need for early and accurate diagnosis has driven the exploration of novel...
9.
Delrue C, Speeckaert R, Oyaert M, De Bruyne S, Speeckaert M
J Clin Med
. 2023 Dec;
12(23).
PMID: 38068480
Raman spectroscopy, a non-invasive diagnostic technique capturing molecular vibrations, offers significant advancements in skin cancer diagnostics. This review delineates the ascent of Raman spectroscopy from classical methodologies to the forefront...
10.
Oyaert M, De Scheerder M, Van Herrewege S, Laureys G, Van Assche S, Cambron M, et al.
Eur J Clin Microbiol Infect Dis
. 2023 Nov;
43(1):177-185.
PMID: 37953413
We assessed the humoral and cellular immune responses after two booster mRNA vaccine administrations [BNT162b2 (Pfizer-BioNTech vaccine)] in cohorts of immunocompromised patients (n = 199) and healthy controls (HC) (n ...